VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at the Immuno-Oncology Summit

By | Conferences, Glioblastoma ("GBM"), Press Releases
IND-enabling data, including restimulation of CMV-specific T-cell immunity in Rhesus Macaques Mechanistic data demonstrating VBI-1901 stimulates innate immunity Data presentation Wednesday, August 30, 2017 VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (VBI), today announced that David Anderson, Ph.D., Chief Scientific...
Read More